Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Local time in host city

Programme

10 Sessions
Saturday
May 07
10:30 - 11:30
Mini-Oral Theatre 2
Pedro Meireles, Portugal;
Rick Haas, The Netherlands
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres near the exhibition. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will not be streamed but authors are invited to upload per-recordings for the online platform.
Mini-Oral
Clinical
Saturday
May 07
10:30 - 11:30
Poster Station 1
Eliana Maria Vasquez Osorio, United Kingdom
Poster Discussions are presented at one of the sessions scheduled at the two poster terminals in the exhibition. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be streamed but authors are invited to upload per-recordings for the online platform.
Poster Discussion
Physics
Saturday
May 07
10:30 - 11:30
Poster Station 2
Henry Mandeville, United Kingdom
Poster Discussions are presented at one of the sessions scheduled at the two poster terminals in the exhibition. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be streamed but authors are invited to upload per-recordings for the online platform.
Poster Discussion
Clinical
Saturday
May 07
11:40 - 12:40
Room D3
Anna Kirby, United Kingdom;
Ben Slotman, The Netherlands
Symposium
Interdisciplinary
Saturday
May 07
13:00 - 14:00
Auditorium 11
Assembly
Brachytherapy
Saturday
May 07
14:15 - 15:30
Room D4
Geraldine Jacobson, USA;
Tim Illidge, United Kingdom
Joint Symposium
Interdisciplinary
Saturday
May 07
14:15 - 15:30
Auditorium 12
Ludwig Dubois, The Netherlands;
Pierre Montay-Gruel, Belgium
Radiosensitivity studies identify more and more biological mechanisms involved in tumour radioresistance. In this context, new drugs and biotechnologies are currently being developed to overcome this tumour radioresistance and improve radiotherapy treatments. This session aims at presenting three emerging radiobiological modifiers derived from: 1- serine/glycine metabolism hyperactivation in lung cancer and drug inhibition strategies, 2- metal nanoparticle radiosensitization, clinical trials and combinatory approaches, and 3- CRISP-Cas9 bioengineering for biomarker, cancer therapy and treatment combinations strategies.
Symposium
Radiobiology
Saturday
May 07
14:15 - 15:30
Room D3
Pedro Lara, Spain;
Sebastien Guihard, France
Symposium
Clinical
Saturday
May 07
14:15 - 15:30
Room D1
Eric Deutsch, France;
Patricia Fernandes, Belgium
Symposium
Clinical
Saturday
May 07
14:15 - 15:30
Auditorium 11
Artur Chyrek, Poland;
Ina Jürgenliemk-Schulz, The Netherlands
Brachytherapy as specific modality in the field of radiotherapy, has a long-standing tradition and contributes essentially in the spectrum of radiation treatments for several tumor sites. Different from external beam radiotherapy, brachytherapy sources are brought into close distance to treatment targets. Therefore, brachytherapy is often invasive and asking for unique kills of the involved team, radiation oncologists, physicists and radiation technologists. During recent years, international efforts have investigated the current educational situation in order to define possible needs for improving skills and availability of professionals interested in brachytherapy. The symposium will address lessons we have learned from surveys among radiation oncology residents in Europe and North America, form the current educational situation of our physicists and form the specific situation in Italy. Based on this knowledge several measures have been taken and programs have been initiated to assure and preserve our brachytherapy skills for the future.
Symposium
Brachytherapy
+(event:"7e8abefd-c7c2-eb11-bacc-000d3adc83c4")